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ABSTRACT: Exercise training and sport activity are important for good health among those 
with type 1 diabetes mellitus (T1DM); however, fear of hypoglycemia is a clear barrier to 
participation. We examined both the main demographic and exercise training risk profiles for 
exercise-associated and nocturnal hypoglycemia, including indicators of unawareness. Mode of 
insulin delivery, whether multiple daily injections (MDI) via pen or continuous subcutaneous 
insulin infusion (CSII) via pump, was an important consideration.  Research Design: Our study 
was based on data from an internet-based survey in the Netherlands that attracted T1DM 
participants who engage in routine exercise or sport activity.  Results: The majority of survey 
participants reported experiencing hypoglycemia either “sometimes” (67.9%) or “regularly” 
(18.5%) during or after exercise, while 74% reported experience of nocturnal hypoglycemia. In 
contrast, only a very small number of survey participants reported complete unawareness 
surrounding symptom severity (< 4%). Overall, regular exercise-associated hypoglycemia 
predicted the report of nocturnal hypoglycemia (OR= 14.44; P < 0.001). Significant demographic 
predictors specific for exercise-associated hypoglycemia were sex, age, and number of years of 
exercise with T1DM (P <0.05). Nocturnal hypoglycemia was influenced by duration of diagnosis 
and daily basal insulin dose requirements (P < 0.05). Mode of insulin delivery (pen/pump) 
significantly influenced both exercise-associated (P= 0.002) and nocturnal (P= 0.042) 
hypoglycemic outcomes, depending on exercise type (endurance/non-endurance). Specifically, 
pump use, in the context of non-endurance exercise, was associated with high risk for both forms 
of hypoglycemia.  Conclusions: While hypoglycemia is prevalent in individuals with T1DM 
who exercise regularly, hypoglycemia unawareness is not. Given that baseline insulin 
requirements were broadly tied to the above risk profiles, we conclude that exercise regimens to 
improve overall insulin sensitivity may be crucial to mitigating risk for hypoglycemic outcomes.   
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Cardiorespiratory fitness achieved through regular exercise is vital to overall health quality, and 
offers a number of health benefits to people with Type 1 Diabetes Mellitus (T1DM) (Huttunen et 
al., 1989; Lehmann et al., 1997).  Measured by maximal oxygen consumption, cardiorespiratory 
fitness is a simple predictor of good glycemic control as gauged by glycosylated hemoglobin 
(HbA1c) levels in individuals with T1DM (Lukacs et al., 2012).  Unfortunately, low exercise 
involvement has been identified as a common lifestyle characteristic contributing to 
cardiometabolic risk in people with T1DM (Leroux et al., 2014).  One of the primary barriers to 
regular exercise participation is the fear of hypoglycemia (Brazeau et al., 2008).  While it is 
recognized that a given person can benefit from keeping track of conditions that promote or 
seemingly protect them from exercise-associated hypoglycemia (Nagi et al., 2010), regular 
exercisers as a group have not been queried to gain a collective profile for this risk.     
Glycemic control, which is a primary treatment goal for T1DM (American Diabetes 
Association, 2003), can be disrupted by physical activity (Riddell & Perkins, 2006).  Muscle 
contraction and insulin action are capable of increasing the disposal of glucose in a potentially 
additive manner (Lai et al., 2010).  Rates of glucose uptake during exercise are increased with 
intensity of physical activity due to muscle contraction mobilizing the glucose transporter 
(Romijn, et al., 1993; Romijn et al., 2000; Richter, et al., 2001).  Normally, insulin decreases 
during exercise so that muscle contraction is the primary stimulus driving glucose uptake 
(Marliss &Vranic, 2002).  Blood glucose concentrations are maintained constant by glucose 
production from the liver (Wasserman & Cherrington, 1991).  Only during high intensity 
exercise does glucose production typically outpace demand from the active muscles (Coker & 
Kjaer, 2005; Marliss &Vranic, 2002).  The situation is quite different for a person with T1DM.  
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There is no mechanism to decrease exogenous insulin levels in response to physical activity 
(Riddell & Perkins, 2006) placing individuals with T1DM at risk for hypoglycemia both during 
and after exercise (Tonoli et al., 2012).  Moreover, the insufficient release of counter-regulatory 
stress hormones (often exacerbated by recent episodes of low blood glucose or preceding 
exercise) can delay symptom presentation surrounding hypoglycemia onset, dangerously 
promoting unawareness and increasing vulnerability to more severe hypoglycemic events 
(Mokan et al., 1994; de Gallen et al., 2006).  While incompletely understood, nocturnal 
hypoglycemia is likely promoted by increased peripheral insulin sensitivity due to exercise, 
coupled with impaired glucose counter-regulatory system response to falling glucose levels 
(Riddell & Perkins, 2006; MacDonald, 1987; McMahon et al., 2007).  Primary prevention of 
hypoglycemia in T1DM is thus ideal, and careful planning is required to decrease the potential 
for hypoglycemia that can occur, not only during or after exercise is performed, but also at night.  
While evidence supports a relatively high level of hypoglycemia unawareness in T1DM (Mokan 
et al., 1994), the extent of hypoglycemia unawareness in regular exercisers is unknown.  
Similarly, the risk profiles for both exercise-associated and nocturnal hypoglycemia in people 
with T1DM who exercise regularly have yet to be fully understood.   
As exogenous insulin administration acutely challenges glycemic control during and after 
exercise, the distinction between multiple daily injections (MDI) via pen and continuous 
subcutaneous insulin infusion (CSII) via pump is potentially an important consideration.  CSII 
therapy has become an increasingly popular alternative to MDI and is touted for generally 
allowing T1DM patients the most precise, near-normal physiological experience of blood 
glucose control (Lenhard & Reeves, 2001; Weissberg-Benchell et al., 2003).  Yet, an 
overwhelming majority of past research endeavors comparing modes of insulin delivery were not 
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executed in the context of exercise (e.g. DeVries et al., 2002; Home et al., 1982; Jakisch et al., 
2008; Simon et al., 2008).  Indeed, there is little to no evidence suggesting pump use confers 
protection from hypoglycemia in the case of regular physical activity.  Although the general 
recommendation is for exercisers to reduce their dose before exercise (Mauvais-Jarvis et al., 
2003; West et al., 2010), even with an appropriate dose reduction, hyperinsulinemia is possible 
due to enhanced muscle sensitivity and increased blood flow augmenting the mobilization of 
insulin from its injection site (Campbell et al., 2013; Marliss & Vranic, 2002; Riddell & Perkins, 
2006).   Given that intensive insulin therapy generally increases the likelihood of hypoglycemia 
during or after exercise (The DCCT Research Group, 1993) and at night (The DCCT Research 
Group, 1993; Yardley et al., 2012), CSII pump use might present an increased risk for regular 
exercisers. 
Despite its challenges, exercise has been widely recommended as an important 
management strategy for T1DM (IDF, 2011). The present study is the first epidemiological 
observation of regular exercisers with T1DM; an attempt to describe the basic risk landscape for 
hypoglycemia and associated unawareness based on real-world experience from recreational 
exercisers and athletes with T1DM in the Netherlands.  This emphasis on “real-world” self-
report is crucial, as most T1DM acute exercise studies to date have investigated risk under very 
controlled research settings (e.g. Huttunen et al., 1989; Mauvais-Jarvis et al., 2003; Yardley et 
al., 2012).  The Dutch population was chosen for study given the high prevalence and steady 
increase in T1DM incidence in the Netherlands in recent years (Ruwaard et al., 1994) and 
relative genetic homogeneity of the Dutch population (Abdellaoui et al., 2013).  Outcomes of 
interest are our primary and secondary markers for poor blood glucose control, namely exercise-
associated and nocturnal hypoglycemia, and symptom (un)awareness.  In addition, we examined 
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the extent to which mode of insulin delivery (pen/pump) is accompanied by an increased 
likelihood of hypoglycemia and/or unawareness, hypothesizing that CSII pump therapy might 
present an increased risk due to the potential for over-insulinization and thus disturbed glycemic 
control. 
RESEARCH DESIGN  
This study was designed to ascertain feedback from individuals with T1DM who engage in 
routine exercise activity either on a recreational or competitive basis.  Data were acquired from 
an anonymous, nationally advertised, internet-based survey launched in the Netherlands. 
Interested participants were directed to the Bas Van de Goor Foundation website to complete the 
survey.  The materials were approved by Yale School of Medicine Human Investigation 
Committee.  No personal health information was linked to participants.  Our structured 
questionnaire collected data from participants ranging from 18 to >70 years of age who were 
reportedly diagnosed with T1DM and engaged in some level of exercise and/or sport activity on 
a regular basis.  Participants were questioned on relevant demographic and exercise 
characteristics including sex, age, number of years diagnosed with T1DM, number of years 
exercising with T1DM, exercise volume/training hours, type of exercise, and the time of day 
during which they primarily engage in exercise.  Exercise volume/training hours referred to 
either “recreational” or “competitive” status.  Recreational status was characterized by physical 
activity levels ranging anywhere from less than one hour per week up to 4 hours per week.  
Alternatively, competitive respondents indicated an exercise training volume of 4-20 hours per 
week.  Type of exercise was divided into endurance (i.e. cycling, running, triathlon, large field 
team sports, etc.) and non-endurance (small field, interval and individual sports) categories.  The 
non-endurance category also included general fitness activities such as golf and Zumba.  
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Concerning exercise time of day, participants could indicate any combination of the following 
options: morning, afternoon, evening, weekend.  Participants were further asked to specify mode 
of insulin delivery (pen/pump) as well as their daily basal insulin dose.  
With regard to experiencing exercise-associated hypoglycemia during or after exercise or 
sport activity, participants were asked to reply either 1) “no, never” 2) “sometimes” or 3) 
“regularly.” Alternatively, experience of nocturnal hypoglycemia was probed through a general 
“yes/no” reply.  Both forms of hypoglycemia were queried in general, not referenced to specific 
exercise sessions.  The outcome of (un)awareness was two-fold, in that we assessed 1) 
participant reaction time and 2) blood glucose concentration surrounding the detection of initial 
symptoms of hypoglycemia.  The first evaluated how soon/well a participant could feel the onset 
of hypoglycemia, and was grouped and assessed at the following reaction time intervals (ranging 
from “poor awareness” to “awareness”): 1) combined complete unawareness and 5-10 minute 
reaction time before symptom escalation (categorized as “poor awareness”), 2) 10-20 minute 
reaction time before symptom escalation, and 3) 20-30 minute reaction time before symptom 
escalation.  The second marker evaluated the concentration of blood glucose at which a 
participant typically detected symptoms of hypoglycemia onset.  Levels were similarly grouped 
and assessed at the following intervals (ranging from “poor awareness” to “awareness”): 1) 
combined complete unawareness and symptom detection at values ≤ 2.9 mmol/l (“poor 
awareness”), 2) detection at values ranging from 3.0 to 3.9 mmol/l, and 3) detection at values ≥ 
4.0 mmol/l.  For both markers, we grouped complete unawareness and poor awareness together 
for the sake of statistical balance, given that so few respondents reported a total lack of 
symptoms.  The resulting category was termed “poor awareness” and would be predicted against 
increasing levels of awareness in our analysis.  
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Statistical Analysis  
Using frequency distributions, we calculated the overall prevalence of hypoglycemia during/after 
exercise and at night.  The same was done for each level of (un)awareness.  Using mean 
calculations and the independent samples t-test procedure, we examined the potential for 
significant differences in daily basal insulin dose requirements across mode of insulin delivery, 
sex, age, duration of diagnosis, number of years exercising with T1DM, exercise volume/training 
hours, and exercise type.  Chi-square analyses were conducted to investigate possible 
associations between each demographic subject characteristic and mode of insulin delivery, as 
well as to examine the hypothetical relationship between the use of pen/pump and any number of 
our 4 key dependent outcome variables.  To further explore the potential impact that mode of 
insulin delivery, in conjunction with other demographic/exercise variables, may have on 
outcomes of hypoglycemia and symptom (un)awareness, we employed logistic regression 
modeling.  A total of 4 models were analyzed through a combination of ordered and regular 
logistic regression procedures, depending on the nature of the outcome (ordinal or binary).  Each 
model controlled for the following known and potential confounders: sex, age, number of years 
diagnosed with T1DM, number of years of exercise with T1DM, exercise volume/training hours, 
type of exercise, exercise time of day, daily basal insulin dose, and mode of insulin delivery.  
Effect modification was assessed uniformly across models through the testing of 24 potentially 
relevant interactions.  Interaction terms were included in the final models based on clinical and 
statistical significance.  Values are expressed as odds ratios (OR) accompanied by 95% 
confidence intervals, and statistical significance was concluded at p < 0.05.  All calculations and 





A total of 385 subjects responded to the survey.  Participants were excluded from analysis if they 
1) did not complete the survey in full (n = 78), and/or 2) demonstrated probable type 2 diabetes 
status through their answer choices (n = 5), leaving an analytic sample of 302 (120 male and 182 
female) subjects.  Key characteristics of T1DM survey participants are described in Table 1, and 
are stratified by mode of insulin delivery.  The sample was relatively balanced, but favored 
respondents who indicated they had engaged in exercise or sport activity for less than 10 years 
since their diagnosis of T1DM (63.9%).  Participants self-identified as “recreational” exercisers 
made up the majority of the sample, while over a third of our respondents characterized 
themselves as “competitive.”  Endurance and non-endurance exercisers each comprised 
approximately half the sample.  With respect to mode of insulin delivery, 173 participants 
(57.3%) reported pen use, while 129 (42.7%) reported pump use.  As indicated in Table 1, a 
significant difference between pen and pump use was found to exist among a number of our 
main demographic groups, including sex (P < 0.001) and age (P < 0.003).  The same applied to 
daily basal insulin dose requirements, for which pump users reported an average insulin dose 
(27.51 ± 17.38 mmol/l) significantly higher than that of pen users (20.40 ± 12.33 mmol/l) (P < 
0.001).   
Risk of Hypoglycemia (During/After Exercise and at Night) 
A high percentage of our survey population of regular exercisers indicated experience with both 
exercise-associated hypoglycemia and nocturnal hypoglycemia.  Specifically, respondents 
reported experience of hypoglycemia either “sometimes” (67.9%) or “regularly” (18.5%) during 
or after exercise or sport activity; 74.2% indicated experience with nocturnal hypoglycemia 
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(Table 2).  Notably, chi-square test of association revealed potential for a significant relationship 
between mode of insulin delivery and experience of hypoglycemia during/after exercise and at 
night (P < 0.001 and P = 0.006, respectively). 
Figure 1 illustrates the results for the logistic regression strictly examining the 
relationship between the primary dependent outcomes: during/after exercise and nocturnal 
hypoglycemia.  Those who indicated having experienced exercise-associated hypoglycemia 
“regularly” were over 14 times more likely to experience nocturnal hypoglycemia (OR = 14.44; 
95% CI: 5.01, 41.62; P < 0.001) compared to those individuals who reported “never” 
experiencing exercise-associated symptoms.  In contrast, the latter group demonstrated increased 
protection from nocturnal hypoglycemia (OR = 0.07; 95% CI: 0.02, 0.20; P < 0.001).  Each 
trajectory was particularly significant among non-endurance exercisers, where experience of 
exercise-associated symptoms “regularly” was associated with report of nocturnal hypoglycemia 
(OR = 41.43; 95% CI: 7.95, 215.87; P < 0.001).  
Table 3 presents separate results for the ordered and regular logistic regression modeling 
of exercise-associated hypoglycemia (“regularly,” “sometimes,” or “never”) and nocturnal 
hypoglycemia (“yes”/ “no”), respectively.  Sex was a significant predictor of hypoglycemia 
during or after exercise, with females 2.4 times more likely to experience hypoglycemia 
“regularly” vs. less often, given all variables held constant (OR = 2.36; 95% CI: 1.20, 4.65; P = 
0.013).  This finding was despite the lack of significant difference in daily insulin requirement 
(female: 24.34 ± 16.25; male: 22.95 ± 13.87; P = 0.467).  No significant difference existed 
between males and females in terms of predicting nocturnal hypoglycemia.  Additionally, 
compared to youngest participants (age 18-30), participants 51 years or older seemed to maintain 
a level of protection from experiencing hypoglycemia “regularly” vs. less often during or after 
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exercise (OR = 0.30; 95% CI: 0.12, 0.73; P = 0.008), but not from experiencing nocturnal 
episodes.  The average basal dose for those in the 18-30 age range (27.54 ± 17.88 mmol/l) was 
significantly higher than average dose requirements for the 31-50 (21.72 ± 13.13 mmol/l) and 
51+ (20.24 ± 12.22 mmol/l) age ranges (P = 0.004).  Diabetes duration proved to be a significant 
predictor of nocturnal hypoglycemia, in that those who had been diagnosed for more than 10 
years were 2.5 times more likely to experience hypoglycemia at night given all variables held 
constant (OR = 2.51; 95% CI: 1.04, 6.08; P = 0.042).  The average daily basal insulin dose for 
those with a longer duration of diabetes (more than 10 years) (25.85 ± 14.77 mmol/l) was 
significantly higher than that of individuals who reported a shorter disease duration (less than 10 
years) (21.18 ± 15.70 mmol/l) (P = 0.012).  Alternatively, the number of years spent engaging in 
exercise with T1DM was only weakly associated with experience of hypoglycemia “regularly” 
vs. less often during or after exercise (P = 0.049), and not associated with the risk of nocturnal 
hypoglycemia.  The average daily basal insulin dose of those exercising for more than 10 years 
since diagnosis (25.31 ± 13.00 mmol/l) was not significantly different from that of those 
exercising for less than 10 years since diagnosis (22.87 ± 16.53) (P = 0.180).  Daily basal insulin 
dose itself was also a significant predictor of nocturnal hypoglycemic events.  That is, for every 
5-unit increase in daily basal insulin dose, individuals became 1.2 times more likely to report 
experience of hypoglycemia at night given all variables held constant (OR = 1.22; 95% CI: 1.06, 
1.39; P = 0.004).  In comparison, daily basal insulin dose was only marginally associated with 
experience of hypoglycemia “regularly” vs. less often during or after exercise (P = 0.059).   
In addition to main effects shown in Table 3, an interaction between type of exercise 
(endurance/non-endurance) and mode of insulin delivery (pen/pump) was observed in both 
contexts of exercise-associated (P = 0.002) and nocturnal hypoglycemia (P = 0.042).  This 
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significant interaction is shown in Figure 2.  Compared to the non-endurance exercisers who 
used pen, those who used a pump demonstrated the largest increased risk for exercise-associated 
hypoglycemia (OR = 4.02; 95% CI: 1.82, 8.87) and nocturnal hypoglycemia (OR = 2.31; 95% 
CI: 0.93, 5.73) alike.  In contrast, among endurance athletes, pump users were seemingly 
protected from exercise-associated hypoglycemia (OR = 0.68; 95% CI: 0.28, 1.62) as well as 
from nocturnal hypoglycemia (OR = 0.59; 95% CI: 0.22, 1.61).  In general, report of 
experiencing exercise-associated hypoglycemia “regularly” was more common in non-endurance 
exercisers (73.2%), suggesting increased overall risk in this group (P = 0.006).  In addition, 
respondents indicating primary involvement in non-endurance training reported an average daily 
basal insulin dose significantly higher than that of endurance-trained exercisers (25.62 ± 16.43 
mmol/l and 21.54 ± 13.61 mmol/l, respectively) (P = 0.026).   Particularly among endurance 
exercisers, pump users reported an average basal dose (25.33 ± 16.16 mmol/l) significantly 
higher than that of pen users (18.32 ± 10.04 mmol/l) (P = 0.006).  The same pattern was 
identified among non-endurance pump (29.17 ± 18.19 mmol/l) and pen users (22.21 ± 13.83 
mmol/l) (P = 0.010). 
Risk of Unawareness and Poor Awareness of Hypoglycemia 
We examined (un)awareness by two different indicators: time and blood glucose concentration.  
Less than 4% of respondents (on average) reported complete hypoglycemic unawareness 
(specifically, 3.3% based on reaction time, and 1.3% based on blood glucose concentration 
surrounding hypoglycemia symptom onset).  In terms of reaction time, 57.6% of respondents 
claimed to detect symptoms between just 5 and 10 minutes before symptom escalation, 
demonstrating general poor awareness based on time.  Overall, those reportedly unaware or who 
indicated awareness of hypoglycemia onset just 5-10 minutes before symptom escalation were 
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3.6 times more likely to experience hypoglycemia “regularly” vs. less often (OR = 3.60; 95% CI: 
1.53, 8.50; P = 0.004).  In comparison, individual reports based on blood glucose concentration 
revealed that the majority of respondents (78.1%) indicated the ability to sense hypoglycemia 
symptoms at blood glucose concentrations greater than or equal to 3.0 mmol/l (59.6% identified 
concentration levels in the 3.0-3.9 mmol/l range, and 18.5% identified increasing concentration 
levels above 4.0 mmol/l) (Table 2).  
Table 4 presents the ordered logistic regression results reflecting the influence of subject 
characteristics on poor awareness in each context of reaction time and blood glucose 
concentration.  With respect to reaction time, middle-aged respondents (age 31-50), compared to 
youngest survey respondents (age 18-30), were 1.8 times more likely to report poor awareness 
(either complete unawareness or 5-10 minute reaction time) vs. a more reasonable reaction time 
surrounding symptom escalation given all variables held constant (OR = 1.83; 95% CI: 1.03, 
3.28; P = 0.041).  Middle-age was similarly associated with poor awareness in terms of blood 
glucose concentration at the time of symptom detection.  Specifically, compared to youngest 
individuals (age 18-30), middle aged respondents (age 31-50) were 2 times more likely to report 
poor awareness (either complete unawareness or symptom detection at blood glucose 
concentrations ≤ 2.9 mmol/l) vs. detection of symptoms at higher blood glucose concentrations 
given all variables held constant (OR = 2.05; 95% CI: 1.14, 3.67; P = 0.016).   
In addition to main effects displayed in Table 4, an interaction between daily basal 
insulin dose and mode of insulin delivery was shown to significantly influence poor awareness in 
terms of blood glucose concentration at the time of symptom detection (P = 0.021).  Specifically, 
with every 5-unit increase in basal insulin dose, pump users became 1.2 times more likely to 
report detection of hypoglycemia onset at highest blood glucose concentrations  (≥ 4.0 mmol/l) 
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vs. lower concentrations given all variables held constant (OR = 1.18; 95% CI: 1.06, 1.32).  In 
contrast, for every 5-unit increase in basal insulin dose, pen users reported little change in 
hypoglycemic awareness (OR = 1.05; 95% CI: 0.91, 1.22).   
DISCUSSION 
Currently, there is a lack of information surrounding hypoglycemia and hypoglycemia 
unawareness in people who exercise regularly with T1DM.  In the present study we surveyed a 
physically active T1DM population from the Netherlands among which both the risks for 
exercise-associated and nocturnal hypoglycemia were found to be prevalent.  In contrast, 
reported hypoglycemia unawareness was essentially absent (< 4%).  Overall, exercise-associated 
hypoglycemia was a strong predictor for nocturnal hypoglycemia, with non-endurance exercisers 
demonstrating the most consistent dual risk.  Distinct demographic features such as sex, age, and 
the number of years exercising with T1DM predicted exercise-associated hypoglycemic 
outcomes, while duration of diagnosis was shown to influence nocturnal hypoglycemia.  
Importantly, insulin requirements, marked by daily basal insulin dose, were shown to either 
marginally or strongly influence outcomes of exercise-associated and nocturnal hypoglycemia, 
respectively.  In addition, both forms of hypoglycemia were similarly marked by a consistent and 
significant interaction between mode of insulin delivery and type of exercise.  This interaction 
indicted an elevated risk for both exercise-associated and nocturnal hypoglycemia among non-
endurance exercisers engaging in CSII vs. MDI therapy; however, no such elevated risks were 
seen among pump-using endurance athletes. 
Exercise is important for good health in people with T1DM (Chimen et al., 2012). 
However, fear of hypoglycemia is a primary barrier to physical activity (Brazeau et al., 2008) 
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and is likely the reason for which a large percentage of the T1DM population remains widely 
inactive (Thomas et al., 2004).  Here we provide preliminary findings surrounding the 
demographic and exercise characteristics that impact the risk profile for hypoglycemia in people 
who exercise regularly.  We also explore the extent to which mode of insulin delivery may 
contribute to T1DM hypoglycemic complications in this physically active population.  As 
emphasized, survey respondents overall were far more likely to report nocturnal hypoglycemia if 
they were prone to regular hypoglycemic episodes surrounding the time of exercise.  The reverse 
was true in the case of those who reported never experiencing exercise-associated hypoglycemia.  
Upon examining this relationship more closely, we found that non-endurance exercisers may 
largely be driving this overall effect.  Indeed, stratifying by exercise type revealed that the non-
endurance exercise group demonstrated a consistent and significant trajectory from report of 
regular exercise-associated hypoglycemia to nocturnal hypoglycemia; however, no such 
significant pattern existed among endurance exercise respondents.  It is important to note that, in 
general, non-endurance exercisers reported an average daily baseline insulin dose significantly 
higher than that of endurance exercisers, which likely indicates reduced overall sensitivity.  In 
contrast, and as expected (Hall, 2013; Kirwan et al., 1993; Hersey et al., 1994), endurance 
exercisers reported a significantly lower average basal dose of insulin, indicative of higher 
insulin sensitivity and likely better glucose control overall.  Research is needed to identify 
whether less insulin sensitivity associated with non-endurance exercise is related to more labile 
glucose control.  In general, non-endurance exercise training is far from well represented in the 
acute exercise literature (Tonoli et al., 2012).     
This overarching relationship between exercise-associated and nocturnal hypoglycemia 
set the stage for an in-depth investigation of the individual risk factors for each.  Our analysis 
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revealed several main effects.  Females, for instance, demonstrated a significantly higher risk for 
exercise-associated hypoglycemia, but not necessarily for nocturnal hypoglycemia.  Average 
basal insulin dosing patterns were no different across males and females.  Moreover, there was a 
lack of model interaction between mode of insulin delivery and sex.  Thus, it could be that the 
difference between the risk for men and women lies within insulin adjustment patterns before, 
during, and after physical activity or within inherent differences in male and female 
physiology/metabolism.  To date, little research has focused on women, but past work has 
highlighted female susceptibility and struggle with poor glycemic control (Wild, 2013).  
Fortunately, females (by and large pump users) were well represented in our sample, but further 
study is needed in this area to explain the apparent increased vulnerability of women.  Also 
exclusive to the outcome of exercise-associated hypoglycemia, older respondents (51+) indicated 
decreased risk of regular hypoglycemic events during or after physical activity.  In looking into 
this population we found that their average daily basal insulin dose requirement was unusually 
and significantly lower than that of younger age groups (18-30), and is thus quite possibly 
driving this protection from risk.  We have seen from the literature that older age is generally 
associated with a decrease in insulin sensitivity and, consequently, an increase in insulin 
requirements (Kahn et al., 1990).  However, this increased resistance is largely driven by an age-
associated decline in physical activity (Kahn et al., 1990).  Here, we are dealing with a 
motivated, physically active older population that appears to be more insulin sensitive as a group.  
This finding parallels that of previous work which demonstrated the potential for exercise 
training to improve insulin sensitivity in older adults (Kahn et al., 1990).  It is also worth noting 
that roughly 60% of older age respondents were split almost equally between endurance 
activities such as cycling and running and low-exertion activities such as walking and golf.  It is 
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possible that the latter activities conferred some protection from risk given the flexibility 
allowing for easy carbohydrate ingestion.  In addition, although a marginally significant 
indicator, increased number of years of regular physical activity with T1DM may prove to 
enhance the risk for exercise-associated hypoglycemia.  Respondents who had engaged in 
exercise for over 10 years since their diagnosis demonstrated a higher propensity for regular 
episodes of hypoglycemia during or after exercise compared to those exercising for less than 10 
years since diagnosis.  We are unaware of previous research that has involved years of training 
with T1DM.  However, the lack of difference between average insulin requirements across years 
of exercise with T1DM, suggests other factors are important.  In contrast, nocturnal 
hypoglycemic events were strongly influenced simply by the number of years of diagnosis, 
where respondents diagnosed for more than 10 years were reportedly at increased risk.  This 
same group of individuals reported a significantly higher average basal insulin dose compared to 
that of individuals characterized by shorter disease duration.  We know from the literature that 
increased duration of diabetes, and thus years of insulin treatment, leads to more frequent and 
severe hypoglycemic events (McCrimmon & Sherwin, 2010; Leese et al., 2003; The DCCT, 
1991) and specifically to nocturnal hypoglycemia (Shalwitz et al., 1990).  While daily basal 
insulin dose may have been weakly correlated with exercise-associated hypoglycemia, it proved 
to be a highly significant influence in the context of nocturnal hypoglycemia, consistent with 
what we would expect as defined by the acute literature (Shalwitz et al., 1990; Amin et al., 
2003).  Indeed, respondents who indicated higher basal insulin dosing patterns were significantly 
more at risk for nocturnal hypoglycemia, reflective of sustained insulin sensitivity that may 
persist hours after exercise (MacDonald, 1987; Campbell et al, 2013). 
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Finally, both outcomes of exercise-associated and nocturnal hypoglycemia were marked 
by an interaction between mode of insulin delivery and type of exercise, suggesting that the 
distinction between endurance and non-endurance exercise training plays a substantial, 
modifying role in the relationship between mode of insulin delivery and hypoglycemia.  This is 
not surprising given that exercise type is known to play a critical role in blood glucose 
fluctuation (Goodyear & Kahn, 1998; Riddell & Perkins, 2006; Vanelli et al., 2006).  
Specifically, endurance exercise training has been associated with a decrease in blood glucose 
concentration during exercise, while non-endurance or anaerobic activity leads to augmentation 
of blood glucose concentration (Riddell & Perkins, 2006).  Yet, to our knowledge, this is the first 
major data with respect to vulnerability to hypoglycemia comparing non-endurance and 
endurance activity in the context of regular exercise training.  In terms of endurance exercise, the 
current interaction places pump users at decreased risk for regular episodes of exercise-
associated hypoglycemia and nocturnal hypoglycemia.  The finding that pump use mitigates the 
risk of regular hypoglycemia in endurance exercisers appears consistent with past studies 
suggesting that CSII may promote tighter blood glucose control (McMahon et al., 2004, Pickup 
et al., 2002, Hunger-Dathe et al., 2003, Schreiver et al., 2013; Misso et al., 2010), and 
subsequently promote a reduction in severe hypoglycemic events (Misso et al., 2010; Bode et al., 
1996).  However, the picture was quite different from the standpoint of non-endurance exercise 
activity and, as such, may challenge the common misconception surrounding the insulin pump’s 
ability to generally eliminate severe hypoglycemic events (Lenhard & Reeves, 2001).  While 
past studies have highlighted that pump use, in general, may reduce the occurrence of severe 
hypoglycemic events by as much as 4-fold compared to MDI treatment (Lenhard & Reeves, 
2001; Bode et al., 1996; Haardt, 1997), our findings demonstrate quite the contrary, with pump-
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using non-endurance trained respondents reporting 4 times increased risk for regular experience 
of exercise-associated hypoglycemia.  The substantial increase in risk for both exercise-
associated and nocturnal hypoglycemia among pump users in the context of non-endurance 
exercise activity, suggests that the idea of potential over-insulinization may prevail (Toni et al., 
2006; Marliss & Vranic, 2002).  However, this hyperinsulinemia may not have to do with pump 
use per se.  Despite the survey nature of our study, insulin dosing patterns were in the expected 
direction, with non-endurance exercisers reporting a significantly higher basal dose requirement.  
While CSII therapy has generated reports of reduced insulin requirements (Weissberg-Benchell 
et al., 2003, Kuroda et al., 2011), pump-using survey respondents overall reported higher 
baseline levels.  Thus, lower underlying insulin sensitivity offers a likely explanation for why 
non-endurance pump users were at an amplified risk for regular episodes of hypoglycemia 
during or after exercise and at night.  Interestingly, stratification across exercise type revealed 
that, among endurance and non-endurance exercisers alike, pump users exhibited, on average, a 
higher basal insulin dose.  Therefore, a difference in insulin requirement does not afford an 
explanation for why pump use seemingly protected endurance exercisers from risk; although the 
absolute magnitude of daily insulin was shifted lower overall in the endurance athletes of both 
modalities.  Still, further work is needed to identify whether distinct insulin adjustments or 
dietary practices may be contributing to this effect among endurance-trained athletes.  
Given the observed overarching relationship between basal insulin requirement and risk 
of hypoglycemia, our findings bring to light an important consideration regarding underlying 
insulin sensitivity to glucose control that is widely uncaptured by acute exercise research.  While 
it is well documented that physical activity acutely lowers blood glucose concentrations and 
increases insulin sensitivity in T1DM individuals (Steppel & Horton, 2004; The DirectNet Study 
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Group, 2006; Landt et al., 1985), very few studies have even come close to being able to 
demonstrate long-term effects in the context of a lifestyle of routine exercise (Stratton et al., 
1987; Lehmann et al., 1997; Wallberg-Henriksson et al., 1982; Heath et al., 1983).  Importantly, 
reduced baseline insulin sensitivity, as gauged by higher average basal insulin dose requirements, 
repeatedly surfaced where exercisers reported increased risk for regular episodes of exercise-
associated or nocturnal hypoglycemia.  Alternatively, we found that respondents most sensitive 
at baseline were overall better protected from risk.  These findings are in accordance with 
Lehmann et al. (1997) whose 3-month exercise training intervention program led to increased 
insulin sensitivity among participants and a decrease in the overall frequency of severe 
hypoglycemic episodes.  The present outcomes suggest that decreased insulin sensitivity overall 
potentially leads to impaired glucose metabolism due to exercise-driven swings in glucose 
control.  It is likely that when these individuals (e.g. non-endurance pump-users) become acutely 
insulin sensitive as a consequence of exercise, a less stable regulatory response leads to 
hypoglycemia.  The next question then becomes why are the insulin requirements for these 
individuals higher in the first place?  These levels are essentially necessary for them to best 
regulate blood glucose in the context of their daily lives, and thus may even reflect exercise 
requirements external to this study.  Ultimately, these results offer a glimpse into what long-term 
glycemic control (or lack thereof) looks like for these individuals in terms of underlying insulin 
sensitivity based on exercise routine.  While non-endurance exercise warrants further study, 
endurance training, as previously noted, has been shown to decrease insulin resistance (Kirwan 
et al., 1993; Hersey et al., 1994), and thus total requirements (Hall, 2013).  It therefore may be 
beneficial for all exercisers with T1DM to supplement their training regimens with endurance 
exercise to confer an overall better level of insulin sensitivity. 
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Finally, the present study shows a dramatic shift from the traditional literature assessing 
hypoglycemia unawareness in T1DM patients.  Examining unawareness in the context of regular 
exercise revealed a much lower overall percentage of unawareness (< 4%) compared to what has 
been reported in the past (26%) (Mokan et al., 1994).  As underscored by our results, T1DM 
individuals who engage in regular exercise are inherently characterized by better symptom 
awareness.  It is likely that the fear of hypoglycemia may be selecting out of this exercise 
population anyone who lacks symptoms entirely.  However, better symptom awareness leaves 
the potential that improved awareness is part of an adaptation of regular exercise.  While only a 
minute fraction of our population indicated a total lack of awareness, just over 20% of 
respondents still reported symptom detection at blood glucose concentration levels ≤ 2.9 mmol/l, 
rendering this group metabolically hypoglycemic, and thus poorly aware.  Therefore, if we were 
to combine poorly aware respondents with those few lacking symptoms entirely, we approach a 
prevalence similar to that reported by Mokan et al. (1994).  In addition, the majority of 
respondents indicated detection of hypoglycemia onset within a very small reaction time window 
(5-10 minutes) before symptom escalation, and thus poor awareness in general.  The present 
study revealed that those who either failed to sense hypoglycemia, or reported a reaction time of 
just 5-10 minutes, were over 3 times more likely to experience hypoglycemia “regularly” during 
or after exercise.  This finding is consistent with the idea that poor awareness, or total lack 
thereof, places one at increased risk for regular or severe hypoglycemia (Mokan et al., 1994; 
Gold et al., 1994).  While surprisingly not visible, we would have expected a similar finding with 
regard to blood glucose, in that those who reported symptom detection at lowest concentrations 
would have demonstrated increased risk for hypoglycemia.  Yet previous research has shown 
that, among T1DM patients with a general lack of symptom awareness, self-report of 
Campbell 24 
 
hypoglycemic events was significantly at odds with what was otherwise indicated by blood 
glucose markers (Kubiak et al., 2004; Donnelly et al., 2005).  Thus, it stands to reason that while 
an individual may be hypoglycemic according to blood glucose concentration, they may not 
always recognize and report it as such.  In general, middle-aged respondents (age 31-50) were 
found to be significantly more at risk for poor awareness in each context of reaction time and 
blood glucose concentration.  It was thus surprising that middle age did not show up as a 
significant main effect predicting hypoglycemia during or after exercise.  Additionally, a 
significant interaction between daily basal insulin dose and mode of insulin delivery appeared in 
the context of blood glucose concentration alone.  It was promising to see consistency in survey 
responses in that lower insulin sensitivity, at least in pump users (reflecting general insulin 
resistance with respect to daily insulin requirements), translated to increased awareness.  This is 
what we would expect based on Mokan et al. (1994), who was able to draw an association 
between increased insulin sensitivity and lack of awareness.  Finally, the literature suggests that 
diabetes duration is also a significant predictor of unawareness (Mokan et al., 1994).  While 
complete unawareness could not be tested due to such a small number of subjects who reported a 
lack of symptoms, we still may have expected a main effect here for our outcome of poor 
awareness; however, duration of diagnosis did not show up in either of our models predicting 
this result.  
There are several limitations inherent in survey studies.  Self-report, for example, may 
have led to the over- or under-estimation of hypoglycemic events and accompanying markers 
(reaction time and blood glucose concentration) of poor awareness surrounding symptom 
severity.  Additionally, the fact that our participants were volunteers suggests that we may have 
been dealing with a motivated subset of T1DM exercisers, one perhaps not fully representative 
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of the entire T1DM exercise population.  Nonetheless, given the energy and dedication 
fundamentally associated with maintaining an exercise routine with T1DM in general, it is likely 
the external population is not entirely dissimilar.  While this survey will generate follow-up 
studies, probing more deeply into diet and insulin adjustment patterns surrounding exercise, the 
data presented here were not assessed in the context of having controlled for either of these.  
Food intake and insulin adjustment are known to have substantial influence on blood glucose 
control and patterns of hypoglycemia (Toni et al., 2006).  In addition, our survey did not gather 
information regarding overall glucose control (e.g., HbA1c levels) or explore the reasoning 
behind why individuals may have taken up CSII therapy.  In some cases it has been shown that 
individuals on the pump may have transferred from MDI due to unstable blood glucose 
fluctuation and recurrent episodes of hypoglycemia (Schreiver et al., 2013; Crenier et al., 2013).  
Frequent hypoglycemia has, in fact, become a common indication for switching to pump use 
(Lenhard & Reeves, 2001).    
 The very nature of our survey design, however, is also what conferred our study its 
greatest strength: “real-world” feedback.  As previously mentioned, this goes far beyond self-
report, in the sense that we were able to gather highly uncontrolled exercise data that most 
closely exemplifies reality for T1DM individuals who regularly engage in physical activity. 
Here, there were no calibrated exercise machines, no stopwatches, and no laboratory 
measurements; just authentic testimony based on training habits that may help to inform others 
with similar profiles.  Finally, our sample population was an asset, in and of itself, given that the 
Netherlands offers a relatively homogenous study base (diminishing the potential for 
confounding by genetic factors) that has generally exhibited a high prevalence and increasing 
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incidence of T1DM (Ruwaard et al., 1994).  To boost external validity, future studies are needed 
to explore the potential for differences across race and ethnicity.  
SUMMARY AND CONCLUSIONS 
In the present study we were able to describe the basic hypoglycemia risk profile of the T1DM 
individual who engages in regular exercise, while observing a number of associations consistent 
with what we’ve seen in smaller, more controlled studies both within and outside of the context 
of physical activity.  There were, however, various nuances in our data that will specifically help 
to inform this unique population of T1DM athletes and help others to join their ranks.  Our 
survey population indicated a wide prevalence of exercise-associated and nocturnal 
hypoglycemia, yet a general lack of symptom unawareness on the whole.  The latter observation 
demonstrates the likely incompatibility of routine exercise and complete unawareness, but also 
the potential for improved awareness due to regular exercise.  Importantly, we found that 
exercise-associated hypoglycemia was a strong predictor for nocturnal hypoglycemia, with sex, 
age, and number of years exercising with T1DM predicting the former, and duration of diagnosis 
influencing the latter.  An overarching theme of higher insulin requirement among those at risk 
was substantiated by the fact that increased daily basal insulin dose itself was influential in both 
outcomes of exercise-associated and nocturnal hypoglycemia.  Finally, mode of insulin delivery 
proved to be a significant influence, interacting with exercise type and daily basal insulin dose in 
the contexts of hypoglycemia and (un)awareness (blood glucose concentration), respectively.  
Elevated risk for both exercise-associated and nocturnal hypoglycemia among non-endurance 
exercisers engaging in CSII vs. MDI therapy may have been dictated by over-insulinization in 
this group due to a lower underlying sensitivity to insulin (and thus higher basal requirements).  
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It is recommended that future studies explore the reasoning behind this increased relative 
baseline resistance among pump users and non-endurance trained athletes alike. 
Until now, we had yet to solicit feedback from T1DM exercisers that would allow us to 
establish the basic profile of risk or protection from hypoglycemia and associated (un)awareness 
in the context of routine physical activity.  Survey responses have enabled us to describe this 
profile, and to importantly highlight the potential of underlying insulin sensitivity, acquired 
through consistent exercise training (especially endurance), to confer overall protection from 
regular hypoglycemic events.  Our work is a precursor of similar future studies that might help to 
expand our understanding of T1DM complications associated with a physically active lifestyle.  
As such, regular exercisers will become better acquainted with how best to gauge and modify 
their risks.  Similarly, individuals deterred by the fear of hypoglycemia may become more 
comfortable approaching the idea of routine exercise - the cardiorespiratory benefits of which are 
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Table 1. Description of the Sample         
Main Demographics    Total (N = 302)  Pen (N = 173) Pump (N = 129)   P-value† 
Sex             p < 0.001 
 Male    120 (39.7)  85 (70.8) 35 (29.2)  
Female    182 (60.3)  88 (48.4) 94 (51.7)    
Age (years)            p = 0.003 
18-30    119 (39.4)  61 (51.3) 58 (48.7)     
31-50    129 (42.7)  70 (54.3) 59 (45.7) 
51+    54 (17.9)  42 (77.8) 12 (22.2) 
No. Years Diagnosed           p < 0.001 
Less than 10 years  140 (46.4)  98 (70.0) 42 (30.0)  
More than 10 years  162 (53.6)  75 (46.3) 87 (53.7) 
No. Years Exercising with T1DM          p = 0.022 
 Less than 10 years  193 (63.9)  120 (62.2) 73 (37.8) 
 More than 10 years  109 (36.1)  53 (48.6) 56 (51.4) 
Exercise Volume/Training Hours          p = 0.511 
Recreational   189 (62.6)  111 (58.7) 78 (41.3) 
Competitive   113 (37.4)  62 (54.9) 51 (45.1) 
Type of Exercise            p = 0.772  
Non-endurance    168 (55.6)  95 (56.6) 73 (43.5) 
Endurance   134 (44.4)   78 (58.2) 56 (41.8) 
Time of Exercise           p = 0.041 
 Combo M/A/E/W*  197 (66.6)  112 (56.9) 85 (43.2)  
Morning only   23 (7.8)   18 (78.3) 5 (21.7) 
 Afternoon only   20 (6.8)   7 (35.0)  13 (65.0) 
 Evening only   56 (18.9)  31 (55.4) 25 (44.6) 
Daily Basal Insulin Dose (mmol/l/d) †† 23.8 ± 15.3  20.4 ± 12.3 27.5 ± 17.4  p < 0.001  
  
Data are in n (%) unless otherwise indicated.  †P values were obtained using a χ
2
 test (categorical) or an independent samples t-test 
(continuous), comparing the demographics of diabetic participants with regards to mode of insulin delivery.  †† Data are expressed as 
mean ± SD. *W= “weekend”.  Six respondents who indicated only a weekend exercise routine were excluded from the analysis, as a 
“weekend-only” survey selection fails to provide sufficient information around exercise “time of day”.  However, those that indicated 




Table 2. Primary Dependent Outcomes       
Hypoglycemia    Total (N = 302)  Pen (N = 173) Pump (N = 129)   P-value† 
During/After Exercise            p < 0.001 
 Never    41 (13.6)  33 (80.5) 8 (19.5) 
 Sometimes   205 (67.9)  118 (57.6) 87 (42.4) 
 Regularly    56 (18.5)  22 (39.3) 34 (60.7)  
Nocturnal Hypoglycemia           p = 0.006 
 No    78 (25.8)  55 (70.5) 23 (29.5)  
 Yes    224 (74.2)  118 (52.7) 106 (47.3) 
Level of Awareness  
Reaction Time            p = 0.173  
Poor Awareness*   174 (57.6)  94 (54.0) 80 (46.0) 
10-20 minutes   102 (33.8)  60 (58.8) 42 (41.2) 
20-30 minutes   26 (8.6)   19 (73.1) 7 (26.9) 
Blood Glucose Concentration           p = 0.614  
 Poor Awareness* *  66 (21.9)  41 (62.1) 25 (37.9) 
 3.0-3.9 (mmol/l)   180 (59.6)  102 (56.7) 78 (43.3) 
 ≥ 4.0 (mmol/)   56 (18.5)  30 (53.6) 26 (46.4)  
* “Poor awareness” includes those reportedly unaware (total lack of symptoms) (3.3%) as well as those who indicated a short reaction 
time of just 5-10 minutes before symptom escalation (57.6%).  Increasing reaction time is associated with improved awareness.   
** “Poor awareness” in the case of blood glucose concentration includes those reportedly unaware (total lack of symptoms) (1.3%) 
and those who indicated symptom detection at blood glucose concentrations ≤ 2.9 mmol/l (20.5%).  Symptom detection at increasing 
blood glucose concentration is associated with improved awareness.   
†P values were obtained using a χ
2









Table 3. Risk of Hypoglycemia During/After Exercise and at Night  
Hypoglycemic Event    During or After Exercise †  Nocturnal †† 
Covariate     OR (adj) (95% CI) P  OR (adj) (95% CI) P  
Sex           
Male (reference)    1.00     1.00     
 Female     2.36 (1.20, 4.65)  0.013  0.95 (0.44, 2.06)  0.899 
Age (years)             
18-30 (reference)    1.00     1.00     
31-50     0.74 (0.40, 1.38)  0.345  1.53 (0.74, 3.14)  0.251 
51+     0.30 (0.12, 0.73)  0.008  0.61 (0.23, 1.66)  0.336 
No. Years Diagnosed            
Less than 10 years (reference)  1.00     1.00    
More than 10 years   1.05 (0.50, 2.22)  0.891  2.51 (1.04, 6.08)  0.042 
No. Years Exercising with T1DM           
 Less than 10 years (reference)  1.00     1.00    
 More than 10 years   2.13 (1.00, 4.52)  0.049  1.67 (0.63, 4.46)  0.303 
Exercise Volume/Training Hours           
Recreational (reference)   1.00     1.00    
Competitive    1.01 (0.55, 1.85)   0.968  1.23 (0.60, 2.52)  0.566 
Type of Exercise             
Time of Exercise            
 Combo M/A/E/W (reference)  1.00     1.00    
Morning only    1.63 (0.54, 4.95)  0.388  0.78 (0.24, 2.55)  0.686 
 Afternoon only    1.58 (0.55, 4.55)  0.399  1.29 (0.38, 4.35)  0.681 
 Evening only    1.45 (0.71, 2.97)  0.311  1.73 (0.70, 4.28)  0.233  
Daily Basal Insulin Dose (/5 mmol/l/d)  1.10 (1.00, 1.20)  0.059  1.22 (1.06, 1.39)  0.004 
Mode of Insulin Delivery (pen/pump)           
    
*Mode of Insulin Delivery*Type of Exercise    0.002     0.042 
Data are adjusted odds ratios (95% CIs).  †Model data were obtained through ordered logistic regression given the ordinal outcome 
(“never,” “sometimes,” “regularly”), and are predicting the risk of experiencing exercise-associated hypoglycemia “regularly” vs. less 
often.  ††Model data were obtained through regular logistic regression given the binary outcome (“yes”/”no”), and are predicting the 
risk of nocturnal hypoglycemia (“yes”).  For each model, all variables were mutually adjusted for the other variables in the table.  
*Covariates Mode of insulin delivery and type of exercise were involved in a significant interaction predicting risk of hypoglycemia 
during/after exercise and at night (See Figure 2).  
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Table 4. Risk of Poor Awareness of Severe Hypoglycemia  
Sensing Onset of Hypoglycemia             Time†      Blood Glucose Concentration†† 
Covariate    OR (adj) (95% CI) P  OR (adj) (95% CI) P  
Sex           
Male (reference)   1.00     1.00     
 Female    1.06 (0.57, 1.96)  0.853  1.17 (0.64, 2.14)  0.609   
Age (years)             
18-30 (reference)   1.00     1.00      
31-50    1.83 (1.03, 3.28)  0.041  2.05 (1.14, 3.67)  0.016 
51+    1.10 (0.49, 2.46)  0.813  1.34 (0.59, 3.06)  0.487 
No. Years Diagnosed            
Less than 10 years (reference) 1.00     1.00    
More than 10 years  0.72 (0.36, 1.46)  0.366  1.88 (0.93, 3.79)  0.080  
No. Years Exercising with T1DM           
 Less than 10 years (reference) 1.00     1.00    
 More than 10 years  0.97 (0.48, 1.93)  0.919  0.95 (0.47, 1.88)  0.871 
Exercise Volume/Training Hours           
Recreational (reference)  1.00     1.00    
Competitive   1.14, 0.65, 2.00)  0.660  1.09 (0.63, 1.91)  0.754 
Type of Exercise             
 Non-endurance (reference) 1.00     1.00 
 Endurance   0.99 (0.57, 1.72)  0.977  1.44 (0.84, 2.49)  0.188 
Time of Exercise            
 Combo M/A/E/W (reference) 1.00     1.00    
Morning only   1.51 (0.52, 4.35)  0.446  1.43 (0.51, 4.07)  0.499 
 Afternoon only   2.66 (0.80, 8.86)  0.111  1.92 (0.73, 5.09)  0.189 
 Evening only   0.53 (0.28, 1.01)  0.053  0.74 (0.38, 1.44)  0.380  
Daily Basal Insulin Dose (/5 mmol/l/d) 0.99 (0.91, 1.08)  0.894   
Mode of Insulin Delivery              
 Pen (reference)   1.00      
 Pump    1.57 (0.90, 2.72)  0.111 
*Basal Dose*Mode of Insulin Delivery N/A        0.021 
Campbell 37 
 
Data are adjusted odds ratios (95% CIs).  †Model data were obtained through ordered logistic regression given the ordinal outcome of 
increasing reaction times, and are predicting the risk of “poor awareness” vs. levels of increasing awareness.  ††Model data were 
obtained through ordered logistic regression given the ordinal outcome of increasing blood glucose concentrations and are similarly 
predicting the risk of “poor awareness” vs. levels of increasing awareness.  For each model, all variables were mutually adjusted for 
the other variables in the table.  *Covariates mode of insulin delivery and daily basal insulin dose were involved in a significant 





























               




               
                
                
                
                
                
                
                
                
                
                
                
                
 
 
              
                
                
                
                
                
 
 
              
                
                
                
                
                
                
                
                







Figure 2. Describes the effect of the significant interaction between type of exercise 
(endurance/non-endurance) and mode of insulin delivery (pen/pump) on experience of 
exercise-associated (E) hypoglycemia (“regularly”) (P = 0.002) and nocturnal (N) 
hypoglycemia (P = 0.042).   
Figure 1. Describes the overall relationship between exercise-associated and nocturnal 
hypoglycemia outcomes.  Experience of exercise-associated hypoglycemia “regularly” 
was associated with increased report of nocturnal hypoglycemia. Those who reportedly 
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